XML 60 R45.htm IDEA: XBRL DOCUMENT v3.25.2
GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)
 12 Months Ended
Jun. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of goodwill
Goodwill as of June 30, 2025, 2024 and 2023 is presented below:
PrestigeConsumer BeautyTotal
Gross balance at June 30, 2023$6,279.2 $1,748.8 $8,028.0 
Accumulated impairments(3,110.3)(929.8)(4,040.1)
Net balance at June 30, 2023$3,168.9 $819.0 $3,987.9 
Changes during the year ended June 30, 2024
Foreign currency translation(64.6)(17.6)(82.2)
Gross balance at June 30, 2024$6,214.6 $1,731.2 $7,945.8 
Accumulated impairments(3,110.3)(929.8)(4,040.1)
Net balance at June 30, 2024$3,104.3 $801.4 $3,905.7 
Changes during the year ended June 30, 2025
Foreign currency translation125.5 31.0 156.5 
Gross balance at June 30, 20256,340.1 1,762.2 8,102.3 
Accumulated impairments(3,110.3)(929.8)(4,040.1)
Net balance at June 30, 2025$3,229.8 $832.4 $4,062.2 
Schedule of indefinite-lived intangible assets Other intangible assets, net as of June 30, 2025 and 2024 are presented below:
June 30,
2025		June 30,
2024
Indefinite-lived other intangible assets $761.0 $944.6 
Finite-lived other intangible assets, net 2,453.8 2,621.0 
Total Other intangible assets, net$3,214.8 $3,565.6 
The changes in the carrying amount of indefinite-lived other intangible assets are presented below:
TrademarksTotal
Gross balance at June 30, 2023$1,895.7 $1,895.7 
Accumulated impairments(944.9)(944.9)
Net balance at June 30, 2023$950.8 $950.8 
Changes during the year ended June 30, 2024
Foreign currency translation(6.2)(6.2)
Gross balance at June 30, 2024$1,889.5 $1,889.5 
Accumulated impairments(944.9)(944.9)
Net balance at June 30, 2024$944.6 $944.6 
Changes during the year ended June 30, 2025
Impairment charges
(212.8)(212.8)
Foreign currency translation29.2 29.2 
Gross balance at June 30, 2025$1,918.7 $1,918.7 
Accumulated impairments
(1,157.7)(1,157.7)
Net balance at June 30, 2025761.0 761.0 
Schedule of finite-lived intangible assets
Intangible assets with finite lives are amortized principally using the straight-line method over the following estimated useful lives:
DescriptionEstimated Useful Lives
License agreements
2-34 years
Customer relationships
2-28 years
Trademarks
2-30 years
Product formulations and technology
2-28 years
Other intangible assets, net as of June 30, 2025 and 2024 are presented below:
June 30,
2025		June 30,
2024
Indefinite-lived other intangible assets $761.0 $944.6 
Finite-lived other intangible assets, net 2,453.8 2,621.0 
Total Other intangible assets, net$3,214.8 $3,565.6 
Intangible assets subject to amortization are presented below:
CostAccumulated AmortizationAccumulated ImpairmentNet
June 30, 2024
License and collaboration agreements
$3,715.1 $(1,422.5)$(19.6)$2,273.0 
Customer relationships741.8 (527.8)(5.5)208.5 
Trademarks311.7 (192.4)(0.5)118.8 
Product formulations and technology83.7 (63.0)— 20.7 
Total$4,852.3 $(2,205.7)$(25.6)$2,621.0 
June 30, 2025
License and collaboration agreements*$3,765.8 $(1,614.9)$(19.6)$2,131.3 
Customer relationships766.0 (568.9)(5.5)191.6 
Trademarks
318.2 (208.4)(0.5)109.3 
Product formulations and technology87.8 (66.2)— 21.6 
Total$4,937.8 $(2,458.4)$(25.6)$2,453.8 

* On March 21, 2025, the KKW Collaboration Agreement was terminated pursuant to the KKW Sale Agreement. As such, the Company derecognized the remaining KKW Collaboration Agreement carrying amount of $142.5 as of the termination date.
Schedule of finite-lived intangible assets weighted average remaining lives
Intangible assets subject to amortization are amortized principally using the straight-line method and have the following weighted-average remaining lives:
Description 
License and collaboration agreements20.2
Customer relationships15.2
Trademarks13.8
Product formulations and technology19.3
Schedule of finite-lived intangible assets, future amortization expense
The estimated aggregate amortization expense for each of the following fiscal years ending June 30 is presented below:
2026$149.4 
2027139.8 
2028136.3 
2029134.2 
2030130.5